ST. LOUIS, Aug. 4, 2022 /PRNewswire/ — Spire Inc. (NYSE: SR) today reported results for its fiscal 2022 third quarter ended June 30. Highlights include: Net loss of $1.4 million ($0.10 per diluted share) compared to net income of $5.3 million, or $0.03 per share in the prior year Net…
Related Posts
LONGi registra um aumento de 44% na receita no primeiro semestre de 2022
XI’AN, China, 6 de setembro de 2022 /PRNewswire/ — No primeiro semestre de 2022 o desempenho operacional da LONGi aumentou…
Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.
Pharma Desk, India: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ivabradine Tablets, 5 mg and 7.5 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Corlanor Tablets, 5…
Read More “Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.” »
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.
Japan Cellulose Nanofibers Market Report 2022-2032: Demand, Production Capacities, Trends, End User Markets, Impact of Global Market Situation and Future Outlook
DUBLIN, Sept. 20, 2022 /PRNewswire/ — The “The Cellulose Nanofibers Market in Japan 2022” report has been added to ResearchAndMarkets.com’s…